Sunday 24 August 2008

Vion Pharmaceuticals Enters Into Agreement With HOVON To Conduct A Phase III Clinical Trial Of Cloretazine(R)

div























Latest News For Lymphoma / Leukemia
Bristol-Myers Squibb And PDL BioPharma Enter Global Alliance To Develop Novel Treatment For Multiple Myeloma
21 Aug 2008

Vion Pharmaceuticals Enters Into Agreement With HOVON To Conduct A Phase III Clinical Trial Of Cloretazine(R)
20 Aug 2008

Asuragen, Inc. Launches Signature� NPM1 Mutations (RUO): A Rapid Multiplex Assay For The Detection Of NPM1 Mutations
19 Aug 2008

View more news...

Latest Videos for Lymphoma
Monitoring and Adherence in CML



Imatinib, or Gleevec, is a targeted antitumor drug that can maintain chronic myelogenous leukemia (CML) in chequer for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...


Monitoring CML



A wide range of laboratory tests is used to monitor a patient's response to therapy for chronic myeloid leukemia. Listen to experts explain the tests and their range of sensitivity...


View more videos...




Most Popular Categories



cancer �
cardiovascular �
dermatology �
hiv �
nutrition �

diabetes �
obesity �
pediatrics �
psychology �
neurology �
alcohol �

urology �
breast cancer �
women's health �
infectious diseases �
respiratory �
sexual health �

gastrointestinal �
pain �
pregnancy �
bones �
medical devices �
medicare �

depression �
prostate �
smoking �
alzheimer's �
allergy �
sleep �

biology �
genetics �
eye health �
sports medicine �
hypertension �
abortion �

health insurance �
autism �
stem cell research �
adhd �
liver disease �
multiple sclerosis �

arthritis �
pharma industry �
seniors �
dentistry �
it �
nursing �

blood �
fertility �

















More info